Name | Franziska Liss |
Affiliation | Chair of Biochemistry and Cell Biology Chair of Biochemistry and Molecular Biology II |
Street | Am Hubland |
Zip Code | 97074 |
City | Würzburg |
Email | E-mail |
Telephone | +49 931 31- 87963 |
Homepage | Homepage |
Section | Biomedicine |
Title of Thesis Project | Transcriptional regulation of cell cycle genes by the Hippo pathway effector YAP and by the Myb-MuvB complex |
Primary Supervisor | Prof. Dr. Stefan Gaubatz |
Member of Thesis Committee | Prof. Dr. Marc Schmidt |
| Dr. rer. nat. Hans Maric |
| |
Conference Contribution | |
Publication Personal Formatting |
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Jessen M, Gertzmann D, Liss F, Zenk F, Bähner L, Schöffler V, Schulte C, Maric HM, Ade CP, von Eyss B, Gaubatz S. Oncogene. 2024 Feb;43(8):578-593. doi: 10.1038/s41388-023-02926-w. Epub 2024 Jan 5.
|
Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration. Fetiva MC, Liss F, Gertzmann D, Thomas J, Gantert B, Vogl M, Sira N, Weinstock G, Kneitz S, Ade CP, Gaubatz S. Nucleic Acids Res. 2023 May 22;51(9):4266-4283. doi: 10.1093/nar/gkad107.
|
IRF8 Is an AML-Specific Susceptibility Factor That Regulates Signaling Pathways and Proliferation of AML Cells.Liss F, Frech M, Wang Y, Giel G, Fischer S, Simon C, Weber LM, Nist A, Stiewe T, Neubauer A, Burchert A, Liefke R. Cancers (Basel). 2021 Feb 12;13(4):764. doi: 10.3390/cancers13040764.
|
|
| Last update Publications 13.01.2024 |
|